JP2025512119A5 - - Google Patents
Info
- Publication number
- JP2025512119A5 JP2025512119A5 JP2025503023A JP2025503023A JP2025512119A5 JP 2025512119 A5 JP2025512119 A5 JP 2025512119A5 JP 2025503023 A JP2025503023 A JP 2025503023A JP 2025503023 A JP2025503023 A JP 2025503023A JP 2025512119 A5 JP2025512119 A5 JP 2025512119A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding fragment
- seq
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210345658.0A CN116925223A (zh) | 2022-04-02 | 2022-04-02 | 抗pd-1单克隆抗体及其衍生物和用途 |
| CN202210345658.0 | 2022-04-02 | ||
| PCT/CN2023/085413 WO2023186077A1 (zh) | 2022-04-02 | 2023-03-31 | 抗pd-1单克隆抗体及其衍生物和用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512119A JP2025512119A (ja) | 2025-04-16 |
| JP2025512119A5 true JP2025512119A5 (enExample) | 2026-04-08 |
Family
ID=88199450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025503023A Pending JP2025512119A (ja) | 2022-04-02 | 2023-03-31 | 抗ｐｄ－１モノクローナル抗体、その誘導体及びその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250297009A1 (enExample) |
| EP (1) | EP4520769A4 (enExample) |
| JP (1) | JP2025512119A (enExample) |
| CN (2) | CN116925223A (enExample) |
| WO (1) | WO2023186077A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119798436A (zh) * | 2023-10-10 | 2025-04-11 | 长春金赛药业有限责任公司 | 抗pd-1单克隆抗体及其应用 |
| CN118388648B (zh) * | 2024-04-16 | 2025-04-01 | 赛业（苏州）生物科技有限公司 | 一种基于全人源抗体鼠的人pd-l1抗体及其制备方法和应用 |
| CN120518767B (zh) * | 2025-05-30 | 2025-11-11 | 中国人民解放军军事科学院军事医学研究院 | 一种pd-1单克隆抗体及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6548640B1 (en) | 1986-03-27 | 2003-04-15 | Btg International Limited | Altered antibodies |
| EP0590058B1 (en) | 1991-06-14 | 2003-11-26 | Genentech, Inc. | HUMANIZED Heregulin ANTIBODy |
| WO1999029888A1 (en) | 1997-12-05 | 1999-06-17 | The Scripps Research Institute | Humanization of murine antibody |
| CN1961003B (zh) | 2004-03-31 | 2013-03-27 | 健泰科生物技术公司 | 人源化抗TGF-β抗体 |
| TWI681969B (zh) * | 2014-01-23 | 2020-01-11 | 美商再生元醫藥公司 | 針對ｐｄ-１的人類抗體 |
| UA122479C2 (uk) * | 2014-01-24 | 2020-11-25 | Дана-Фарбер Кенсер Інстітьют, Інк. | Виділена молекула антитіла, яка зв’язується з людським білком програмованої смерті-1 (pd-1) |
| RU2656181C1 (ru) * | 2016-07-13 | 2018-05-31 | Закрытое Акционерное Общество "Биокад" | Анти-pd-1-антитела, способ их получения и способ применения |
| CN107840887B (zh) * | 2016-09-21 | 2022-03-25 | 基石药业（苏州）有限公司 | 一种新的pd-1单克隆抗体 |
| KR20230003178A (ko) * | 2020-04-29 | 2023-01-05 | 치아타이 티안큉 파마수티컬 그룹 주식회사 | PD-1 및 TGF-β에 대한 이중 기능성 단백질 |
-
2022
- 2022-04-02 CN CN202210345658.0A patent/CN116925223A/zh active Pending
-
2023
- 2023-03-31 WO PCT/CN2023/085413 patent/WO2023186077A1/zh not_active Ceased
- 2023-03-31 EP EP23778441.8A patent/EP4520769A4/en active Pending
- 2023-03-31 CN CN202380031078.7A patent/CN118946587A/zh active Pending
- 2023-03-31 US US18/853,160 patent/US20250297009A1/en active Pending
- 2023-03-31 JP JP2025503023A patent/JP2025512119A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20210109520A (ko) | 항체 및 이의 용도 | |
| CN119241717A (zh) | 用于治疗癌症的dll3/cd3结合蛋白 | |
| JP2021508469A5 (enExample) | ||
| US20240239878A1 (en) | Binding molecule against dll3 and use thereof | |
| JP2023525827A (ja) | 抗ｃｄ７３抗体およびその使用 | |
| CN113474372A (zh) | 一种抗ceacam5的单克隆抗体及其制备方法和用途 | |
| KR20190117493A (ko) | 항 pd-1 항체 및 그의 용도 | |
| JP2022535553A5 (enExample) | ||
| RU2017145150A (ru) | Антитело против pdl-1, его фармацевтическая композиция и применение | |
| TW201829467A (zh) | 抗ｃｄ３抗體及含有該抗體的分子 | |
| KR102580319B1 (ko) | 항 ceacam6 항체 및 사용 방법 | |
| US20260116991A1 (en) | Monoclonal antibody for specifically recognizing glypican-3, and application thereof | |
| CN113710271A (zh) | 抗cd228抗体和抗体-药物缀合物 | |
| US20250179187A1 (en) | Anti pd-l2 antibody | |
| US20250257130A1 (en) | Anti-ror1 antibodies | |
| JP2024542944A5 (enExample) | ||
| JP2025510642A5 (enExample) | ||
| JP2024507959A (ja) | 抗Ｓｉｇｌｅｃ１５抗体およびその使用 | |
| WO2023221935A1 (zh) | 结合pd-l1和cldn18.2的抗体及其用途 | |
| JP2025513930A5 (enExample) | ||
| US20250002605A1 (en) | Bispecific antibody and use thereof | |
| JP2024533993A5 (enExample) | ||
| JP2024508597A5 (enExample) | ||
| KR20260016944A (ko) | 항-클라우딘18.2 항체 및 이의 제조 및 사용 방법 | |
| WO2025239422A1 (ja) | コートマータンパク質複合体サブユニットベータ２に対する抗体 |